We've found
4,191
archived clinical trials in
Constipation
We've found
4,191
archived clinical trials in
Constipation
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C)
Updated: 10/3/2017
Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials